Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer
Author:
Funder
Russian Science Foundation
Russian Fund for Basic Research
Basic Scientific Research Program project
Publisher
Elsevier BV
Subject
Urology
Reference100 articles.
1. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James;Lancet,2016
2. Abiraterone for prostate cancer not previously treated with hormone therapy;James;N Engl J Med,2017
3. Current therapeutic options in metastatic castration-resistant prostate cancer;Ingrosso;Semin Oncol,2018
4. Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology;Nuhn;Eur Urol,2019
5. Making CAR T cells a solid option for solid tumors;Schmidts;Front Immunol,2018
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in and prospects of immunotherapy for prostate cancer;Cancer Letters;2024-10
2. Application effect of case management nursing based on patient safety in patients with prostate cancer;World Journal of Clinical Cases;2024-09-26
3. Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies;Cancers;2024-09-06
4. Exploring the current potential of immunotherapeutic-based treatment approaches for the management of oral cancer: An updated review;Oral Oncology Reports;2024-06
5. pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery;Journal of Drug Targeting;2024-05-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3